Company: INV
Filing Date: 2025-10-23
Form Type: S-1
Source: 0001140361-25-039085
Chunk: 21

Company: Innventure, Inc.
Filing Date: 2025-10-23
Form: S-1
Chunk 21
---
 advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. We will remain an emerging growth company until the earlier of (1) December 21, 2026, (2) the last day of the fiscal year (a) in which we have total annual gross revenue of at least $1.235 billion or (b) in which we are deemed to be a large accelerated filer, which means the market value of shares of our Common Stock that are held by non-affiliates exceeds $700.0 million as of the prior June 30, and (3) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period. Risk Factors Our business is subject to numerous risks and uncertainties, including those highlighted in the section titled “ Risk Factors,” that represent challenges that we face in connection with the successful implementation of our strategy and growth of our business. Corporate Information The mailing address of our principal executive office is 6900 Tavistock Lakes Blvd, Suite 400, Orlando, Florida 32827, and our telephone number is (321) 209-6787. 7 TABLE OF CONTENTS THE OFFERING Issuer Innventure, Inc. Shares of Common Stock that may be offered and sold from time to time by the Selling Stockholders named herein or their permitted transferees Up to 24,250,470 shares of Common Stock, which includes (i) up to 12,000,000 shares of Common Stock that may be issued upon conversion of the Convertible Debentures issued and issuable to Yorkville pursuant to the Purchase Agreements; (ii) up to 9,000,000 shares of Common Stock that we may issue and sell to Yorkville from time to time, subject to certain limitations and conditions, pursuant to the SEPA, in each case with respect to (i) and (ii) subject to the ownership limitations described therein; and (iii) 3,250,470 shares of Common Stock pursuant to the Subscription Agreements, consisting of (a) 1,625,235 shares of Common Stock issued to the Subscribers and (b) 1,625,235 shares of Common Stock that may be issued upon exercise of the Series A Warrants. Shares of Common Stock outstanding (excluding shares issuable upon exercise of the Series A Warrants) 58,046,433 (as of October 14, 2025) Use of proceeds We will